Healthcare at Home appoints Peter Nicklin as Chairman of the Board

Palladian Investment Partners is pleased to announce the appointment of Peter Nicklin as Chairman of the Board of Healthcare at Home. Peter joined the board as a non executive director in September 2018.

With over 30 years’ operational management experience across a broad international healthcare landscape including pharmaceuticals, biologics, vaccines, medtech and healthcare services, Peter has contributed a wealth of experience to the Healthcare at Home Board. He has significant global experience in healthcare business development leadership. His previous roles include Corporate Vice President and EMEA President of Baxter International, Board Member of Bayer Healthcare AG and Western and Central Europe lead for Novartis.

Peter’s most recent leadership role was as CEO and Member of the Board of Amann Girrbach AG, the leading innovator in digital dental prosthetics, based in Koblach, Austria, which he held from 2018 to 2020. Additionally, he is Chairman of the Board of Versantis, a Swiss pharmaceutical company developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease.

A Chartered Accountant by training, Peter began his career at PricewaterhouseCoopers, after earning a bachelor’s degree at the University of Lancaster.